tanzania times : Latest News and In-depth Analysis
Contact Us
Search

Travel

tanzania times : Latest News and In-depth Analysis
HomeTravel
Travel

Jan 11, 2025

Trina Storage Retains Top Rank in BloombergNEF's 2024 Global Storage Providers and Integrators Bankability Survey

CHANGZHOU,China,Jan. 10,2025-- Recently,Trina Storage has once again secured a top spot in BloombergNEF\'s (BNEF) Energy Storage System Cost Survey 2024,acknowledged for its cutting-edge products,tec

All News

Travel

GENERAL LINK Inc. Launches Special Campaign for Overseas Guests at GL Terrace

TOKYO,Feb. 25,2025-- GENERAL LINK Inc. has announced an exciting new campaign starting March 1st,2025,aimed at overseas travelers visiting Japan. The campaign will offer free optionsatGL Terrace, a lu

Feb 26, 2025

ZTO to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 18, 2025 U.S. Eastern Time

SHANGHAI,Feb. 25,2025-- ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) ("ZTO" or the "Company"),a leading and fast-growing express delivery company inChina,today announced th

Feb 26, 2025

How 51Talk is Redefining Online Education Through AI--from the Boardroom to the Classroom

SINGAPORE,Feb. 25,2025--51Talk,an online English language education platform,has announced plans to launch a comprehensive,AI-powered systems upgrade across its business operations within the coming m

Feb 26, 2025

China committed to acting as an 'enabler'

BEIJING,Feb. 25,2025-- A report from People\'s Daily: Recently,a foreign scholar described China as an "enabler." This term vividly encapsulates China\'s commitment to building a community w

Feb 26, 2025

Travel

IIIF150 Unveils Latest Flagship Raptor 5G at MWC2025

BARCELONA,Spain,Feb. 25,2025-- IIIF150,the imaginative ultra-thin rugged phone manufacture,announced their new flagship Raptor 5G which will be showcased in Barcelona,and different tests onsite to cha

Feb 26, 2025

CStone Announces Publication of GEMSTONE-303 Study Results for Sugemalimab (Cejemly®) in JAMA

Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem

Feb 26, 2025

1 ... 56 57 58 59 60 61 62 ... 117